Canakinumab in addition to phosphate-binding and phosphaturia-inducing therapy were effective in achieving remission in a child with a large familial calcinotic tumour
dc.contributor.author | Ochoa, Maria | |
dc.contributor.author | Jurencak, Roman | |
dc.contributor.author | Smit, Kevin | |
dc.contributor.author | Carsen, Sasha | |
dc.contributor.author | Sawyer, Sarah L. | |
dc.contributor.author | Robinson, Marie -Eve | |
dc.contributor.author | Khatchadourian, Karine | |
dc.contributor.author | Cheng, Hooi Peng | |
dc.contributor.author | Pag, Marika | |
dc.contributor.author | Werier, Joel | |
dc.contributor.author | Ward, Leanne Marie | |
dc.date.accessioned | 2025-01-20T20:07:53Z | |
dc.date.available | 2025-01-20T20:07:53Z | |
dc.date.issued | 2023 | |
dc.description.abstract | We describe the clinical evolution of a patient with tumoral calcinosis due to a pathogenic variant in the GALNT3 gene presented with a large mass overlying her left hip associated complicated by inflammatory flares. Therapy (sevelamer, acetazolamide, and probenecid) was unsuccessful in preventing tumour surgeries, therefore, interleukin-1 & beta; monoclonal antibody therapy was added; this was successful in the prevention of tumour re-growth. This case highlights the importance of assessing and treating the inflammatory aspect of calcinotic tumour. | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1016/j.bonr.2023.101695 | |
dc.identifier.issn | 2352-1872 | |
dc.identifier.uri | https://doi.org/10.1016/j.bonr.2023.101695 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/91857 | |
dc.identifier.wosid | WOS:001043566100001 | |
dc.language.iso | en | |
dc.revista | Bone reports | |
dc.rights | acceso restringido | |
dc.subject | Acetazolamide | |
dc.subject | Familial tumoral calcinosis | |
dc.subject | GLANT3 mutation | |
dc.subject | Sevelamer | |
dc.subject | Anti-IL1 beta antibody | |
dc.subject | Probenecid | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Canakinumab in addition to phosphate-binding and phosphaturia-inducing therapy were effective in achieving remission in a child with a large familial calcinotic tumour | |
dc.type | artículo | |
dc.volumen | 19 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |